A new therapeutic target for proteasome inhibitor resistant multiple myeloma

  • Pitson, Stuart M. (Primary Chief Investigator (PCI))
  • Spencer, Andrew (Chief Investigator (CI))
  • Wallington-Gates, Craig T. (Chief Investigator (CI))
  • Flynn, Bernard (Associate Investigator (AI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/19 → 31/12/21

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): A$676,588.50

Keywords

  • myeloma
  • proteasome
  • endoplasmic reticulum
  • targeted therapy
  • sphingolipids